However, a recent study evaluating a variety of CSF and plasma biomarkers found that protein aptamers of TREM2 also showed a predictive ability for AD status, supporting the idea that microglial markers may have additional value in the differential diagnosis of AD.47 This evidence concerns the gene TREM2 and Alzheimer disease.